Fresenius Medical Care (FMS) Competitors

Natera (NASDAQ:NTRA) and Fresenius Medical Care (NYSE:FMS) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, community ranking, earnings, profitability, dividends, valuation, institutional ownership and media sentiment.

Which has more risk & volatility, NTRA or FMS?

Natera has a beta of 1.79, indicating that its share price is 79% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.85, indicating that its share price is 15% less volatile than the S&P 500.

Do analysts prefer NTRA or FMS?

Natera presently has a consensus price target of $182.12, indicating a potential upside of 19.44%. Fresenius Medical Care has a consensus price target of $27.80, indicating a potential downside of 5.13%. Given Natera's stronger consensus rating and higher probable upside, equities research analysts plainly believe Natera is more favorable than Fresenius Medical Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natera	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	3.00
Fresenius Medical Care	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Is NTRA or FMS more profitable?

Fresenius Medical Care has a net margin of 3.43% compared to Natera's net margin of -14.01%. Fresenius Medical Care's return on equity of 6.04% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natera	-14.01%	-26.23%	-14.27%
Fresenius Medical Care	3.43%	6.04%	2.69%

Does the media favor NTRA or FMS?

In the previous week, Natera had 17 more articles in the media than Fresenius Medical Care. MarketBeat recorded 24 mentions for Natera and 7 mentions for Fresenius Medical Care. Natera's average media sentiment score of 1.53 beat Fresenius Medical Care's score of 1.43 indicating that Natera is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natera	21 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Fresenius Medical Care	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals hold more shares of NTRA or FMS?

99.9% of Natera shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care shares are held by institutional investors. 7.6% of Natera shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in NTRA or FMS?

Natera received 70 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 68.90% of users gave Natera an outperform vote while only 54.64% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
Natera	Outperform Votes 494 68.90%	Underperform Votes 223 31.10%
Fresenius Medical Care	Outperform Votes 424 54.64%	Underperform Votes 352 45.36%

Which has stronger valuation & earnings, NTRA or FMS?

Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natera	$1.83B	11.37	-$434.80M	-$1.47	-103.73
Fresenius Medical Care	$19.49B	0.88	$540.07M	$1.12	26.16

Summary

Natera beats Fresenius Medical Care on 11 of the 18 factors compared between the two stocks.